Everence Capital Management Inc Laboratory Corp Of America Holdings Transaction History

Everence Capital Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$209.01 - $232.56 $395,028 - $439,538	-1,890 Reduced 25.89%	5,410 $1.18 Million
Q4 2023 Jan 30, 2024	BUY	$197.69 - $227.29 $650,400 - $747,784	3,290 Added 82.04%	7,300 $1.66 Million
Q3 2023 Oct 16, 2023	BUY	$201.05 - $221.7 $379,984 - $419,013	1,890 Added 89.15%	4,010 $806,000
Q4 2022 Jan 31, 2023	SELL	$203.72 - $248.97 $419,663 - $512,878	-2,060 Reduced 49.28%	2,120 $499,000
Q2 2022 Jul 26, 2022	BUY	$213.86 - $277.87 $132,593 - $172,279	620 Added 17.42%	4,180 $980,000
Q4 2020 Feb 01, 2021	BUY	$186.91 - $214.42 $269,150 - $308,764	1,440 Added 67.92%	3,560 $725,000
Q3 2020 Feb 01, 2021	BUY	$167.03 - $201.3 $354,103 - $426,756	2,120 New	2,120 $399,000
Q4 2017 Feb 02, 2018	SELL	$147.99 - $163.95 $395,133 - $437,746	-2,670 Closed	0 $0
Q3 2017 Oct 31, 2017	BUY	$149.47 - $160.56 $399,084 - $428,695	2,670	2,670 $403,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Everence Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Everence Capital Management Inc with notifications on news.